WEST PHARMACEUTICAL SERVICES INC
WSTUS売上高
$3.1B
百万USD
営業利益
$585M
百万USD
純利益
$494M
百万USD
ROE
15.5%
最新FY
EPS
$6.79
USD / 株
配当
$0.86
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $671M | $151M | $1.99 |
| FY2021 | Q2 | $724M | $187M | $2.47 |
| FY2021 | Q3 | $707M | $176M | $2.31 |
| FY2021 | FY | $2.8B | $662M | $8.67 |
| FY2022 | Q1 | $720M | $174M | $2.29 |
| FY2022 | Q2 | $771M | $189M | $2.48 |
| FY2022 | Q3 | $687M | $121M | $1.59 |
| FY2022 | FY | $2.9B | $586M | $7.73 |
| FY2023 | Q1 | $717M | $140M | $1.85 |
| FY2023 | Q2 | $754M | $155M | $2.06 |
| FY2023 | Q3 | $747M | $161M | $2.14 |
| FY2023 | FY | $2.9B | $593M | $7.88 |
| FY2024 | Q1 | $695M | $115M | $1.55 |
| FY2024 | Q2 | $702M | $111M | $1.51 |
| FY2024 | Q3 | $747M | $136M | $1.85 |
| FY2024 | FY | $2.9B | $493M | $6.69 |
| FY2025 | Q1 | $698M | $90M | $1.23 |
| FY2025 | Q2 | $767M | $132M | $1.82 |
| FY2025 | Q3 | $805M | $140M | $1.92 |
| FY2025 | FY | $3.1B | $494M | $6.79 |
| FY2026 | Q1 | $845M | $139M | $1.92 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | $2.1B | $2.8B | $2.9B | $2.9B | $2.9B | $3.1B |
| 営業利益 | $197M | $229M | $240M | $297M | $407M | $752M | $734M | $676M | $570M | $585M |
| 純利益 | - | - | - | - | $346M | $662M | $586M | $593M | $493M | $494M |
| 総資産 | $1.7B | $1.9B | $2.0B | $2.3B | $2.8B | $3.3B | $3.6B | $3.8B | $3.6B | $4.3B |
| 純資産 | $1.1B | $1.3B | $1.4B | $1.6B | - | - | - | - | - | - |
| 自己資本 | - | - | - | - | $1.9B | $2.3B | $2.7B | $2.9B | $2.7B | $3.2B |
| 営業CF | $219M | $263M | $289M | $367M | $473M | $584M | $724M | $777M | $653M | $755M |
| EPS | $1.91 | $1.99 | $2.74 | $3.21 | $4.57 | $8.67 | $7.73 | $7.88 | $6.69 | $6.79 |
| BPS | - | - | - | - | $25.03 | $31.44 | $36.22 | $39.30 | $37.10 | $44.10 |
| ROE | - | - | - | - | 18.7% | 28.3% | 21.8% | 20.6% | 18.4% | 15.5% |